600 patients66,869 observations120 daysLIVE

Patient P-01768

Synthetic patientNBL-101 · Day 100 · 35–44 · M · baseline S20Steering view · 3DOpen companion preview
Therapy response
Declining
Tolerance
Deteriorating
GI state
Stable
Inflammatory state
Deteriorating
Nutritional resilience
Stable
Discontinuation risk
53%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S20
  2. Day 75 Trajectory diverged from predictionObserved response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 75.

Primary contributors, last 14 days
  • Treatment adherence-24
  • Toxicity+17
  • Inflammatory activity+5
  • Nutritional resilience+4

What helped?

No interventions yet.

    LIFE OS recommendation
    GI Support Protocol GI-04
    64%
    probability of meaningful tolerance improvement
    • 284 similar trajectories
    • 86% showed improvement
    • median effect visible after 8 days

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    GI burden
    Companion
    50/100
    worsening · +8.0 vs previous 14 d
    Toxicity
    Blood
    55.8/100
    worsening · +21.9 vs previous 14 d
    Sleep quality
    Wearable
    16.9/100
    worsening · -7.0 vs previous 14 d
    Energy level
    Daily log
    2.7/10
    worsening · -1.3 vs previous 14 d
    Stress level
    Daily log
    6.5/10
    worsening · +0.7 vs previous 14 d
    Steps
    Wearable
    6,881
    worsening · -513 vs previous 14 d
    Adherence
    Companion
    66.3 %
    worsening · -13.9 vs previous 14 d
    This trajectory is decaying — what would help, what would not
    Steering view →

    Heading towards failing · 36 from the failing basin, 53 from restoration.

    Would help
    • GI-04 GI Support Protocol
      75% improved among 120 similar · onset 8 d · confidence 61%
    • ME-01 Monitoring Escalation
      100% improved among 73 similar · onset 3 d · confidence 68%
    • NP-02 Dietary Support Protocol
      68% improved among 59 similar · onset 10 d · confidence 68%
    Would not help
    • Keep fat low
      GI +5 next day on high-intake days · n 19
    • Keep histamine low
      GI +4.3 next day on high-intake days · n 23
    • Keep simple carbs low
      GI +4.1 next day on high-intake days · n 18
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Dietary fat load
      +5detractor · 95%
    • Histamine load
      +4.3detractor · 95%
    • Simple carbohydrates
      +4.1detractor · 95%
    • Insoluble fibre
      -2no signal · 43%
    • Alcohol
      +1.5no signal · 34%
    • Spicy / capsaicin
      +0.3no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Inflammatory signalling 85
      • DNAIL6 -174 variant raises baseline inflammatory tone
      • MicrobiomeBacteroides fragilis expansion
      • BloodInflammatory load index 56
      • WearableHRV 25 ms, trending down
    • Mucosal barrier integrity 60
      • DNAFUT2 non-secretor lowers mucosal fucosylation
      • Daily logGI symptom score 50 and rising
      • WearableSleep 5.8 h, below personal baseline
    • Butyrate / short-chain fatty acid production 55
      • MicrobiomeButyrate capacity 42/100
      • Daily logFibre intake low in recent food logs
    • Drug metabolism and exposure 20
      • BloodToxicity index 56
    • Autonomic recovery 20
      • WearableShort sleep window
    DNA
    Fictional pharmacogenomic panel
    • FUT2 rs601338 AA (non-secretor)
      Reduced mucosal fucosylation
    • IL6 -174 G/C
      Higher inflammatory tone
    • CYP2D6 Normal metabolizer
      Expected exposure
    Microbiome
    Shannon diversity 2.6 · butyrate capacity 42/100
    • Akkermansia muciniphilaNormal
    • Faecalibacterium prausnitziiNormal
    • Bacteroides fragilisHigh
    • Bifidobacterium longumLow
    • EnterobacteriaceaeHigh
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    25 ms
    Sleep
    5.5 h
    Steps
    7,578
    Resting HR
    69 bpm
    Daily log: GI score 50, nutritional resilience 45, adherence 66.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
    • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Avoid known triggers for now: fried or oily food, dairy, alcohol
    What to do
    • Track each bowel movement today: time, stool form, urgency, overnight waking
    • Keep the current walking rhythm
    • Protect a 7.5-hour sleep window; screens off 30 minutes before
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the scheduled dose as agreed with your care team
    • Electrolyte solution, one sachet after any loose stool
    • Fictional demo item: oral nutrition supplement with lunch

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0181926%S1372
    P-0160426%S0171
    P-0138626%S1370
    P-0135227%S2070
    P-0175025%S1669
    P-0169938%S04GI-04improved69
    P-0150826%S1868
    P-0175425%S1468
    P-0150927%S1768
    P-0187525%S1167
    P-0181727%S1467
    P-0187731%S01CR-01improved67